As of September 09, 2026, Lexaria Bioscience's top three insider holders are Christopher Bunka (Director, 373.54K shares), Christopher Bunka (Chief Executive Officer, 281.91K shares), Christopher Bunka (Director, 273.54K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Christopher Bunka | Director | 647,086 | 0 | 647,086 | 85.8% | 18 Mar, 2026 |
| 2 | Richard Christopher | Chief Executive Officer | 65,000 | 0 | 65,000 | 8.6% | 30 Jul, 2025 |
| 3 | William Edward Mckechnie | Director | 18,191 | 0 | 18,191 | 2.4% | 30 Jul, 2025 |
| 4 | Albert L Jr Reese | Director | 10,917 | 0 | 10,917 | 1.4% | 25 May, 2022 |
| 5 | John Martin Docherty | President Cso | 5,376 | 0 | 5,376 | 0.7% | 30 Jul, 2025 |
| 6 | Catherine C. Turkel | Director | 4,600 | 0 | 4,600 | 0.6% | 13 Aug, 2024 |
| 7 | Gregory Downey | Chief Financial Officer | 1,954 | 0 | 1,954 | 0.3% | 18 Oct, 2022 |
| 8 | Vanessa Carle | Secretary | 750 | 0 | 750 | 0.1% | 30 Jul, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 17 Mar, 2026 | Christopher Bunka | Director | Disposed G | 100,000 | $0.00 | $0 | 273,543 | Direct |
| 29 Jul, 2025 | Vanessa Carle | Secretary | Acquired P | 750 | $0.91 | $683 | 750 | Direct |
| 29 Jul, 2025 | Richard Christopher | Chief Executive Officer | Acquired P | 15,000 | $0.91 | $13.64K | 65,000 | Direct |
| 29 Jul, 2025 | William Edward Mckechnie | Director | Acquired P | 5,000 | $0.91 | $4.53K | 18,191 | Direct |
| 29 Jul, 2025 | John Martin Docherty | President Cso | Acquired P | 5,376 | $0.93 | $4.99K | 5,376 | Direct |
| 29 Jul, 2025 | William Edward Mckechnie | Director | Acquired P | 5,000 | $0.91 | $4.53K | 18,191 | Direct |
| 29 Jul, 2025 | William Edward Mckechnie | Director | Acquired P | 5,000 | $0.91 | $4.53K | 18,191 | Direct |
| 29 Jul, 2025 | Christopher Bunka | Director | Acquired P | 15,600 | $0.92 | $14.38K | 270,012 | Indirect |
| 30 Jul, 2025 | Christopher Bunka | Director | Acquired P | 11,900 | $0.91 | $10.87K | 281,912 | Indirect |
| 15 May, 2025 | Baljinder Bhullar | Director | Acquired A | 11,000 | $0.00 | $0 | 11,000 | Direct |
| 15 May, 2025 | Michael Elliot Shankman | Chief Financial Officer | Acquired A | 50,000 | $0.00 | $0 | 100,000 | Direct |
| 15 May, 2025 | Michael Elliot Shankman | Chief Financial Officer | Acquired A | 50,000 | $0.00 | $0 | 100,000 | Direct |
| 15 May, 2025 | Michael Elliot Shankman | Chief Financial Officer | Acquired A | 50,000 | $0.00 | $0 | 100,000 | Direct |
| 15 May, 2025 | Richard Christopher | Chief Executive Officer | Acquired A | 150,000 | $0.00 | $0 | 350,000 | Direct |
| 15 May, 2025 | Vanessa Carle | Secretary | Acquired A | 15,000 | $0.00 | $0 | 75,000 | Direct |
| 15 May, 2025 | Albert L Jr Reese | Director | Acquired A | 11,000 | $0.00 | $0 | 43,000 | Direct |
| 15 May, 2025 | Albert L Jr Reese | Director | Acquired A | 11,000 | $0.00 | $0 | 43,000 | Direct |
| 15 May, 2025 | Albert L Jr Reese | Director | Acquired A | 11,000 | $0.00 | $0 | 43,000 | Direct |
| 15 May, 2025 | John Martin Docherty | President | Acquired A | 150,000 | $0.00 | $0 | 310,834 | Direct |
| 15 May, 2025 | Christopher Bunka | Director | Acquired A | 11,000 | $0.00 | $0 | 184,834 | Direct |